Blog
mPEG-PLA Polymer: A Key Component in Nanoparticle Drug Delivery
The landscape of drug delivery systems has evolved significantly in recent years, with nanotechnology playing a pivotal role. One of the noteworthy innovations in this space is Cynviloq, a nanoparticle formulation of the chemotherapeutic agent paclitaxel. At the core...
Introduces Sterile PLGA 50:50 for Treptorelin Depot Formulation
Webinar on Revolutionizing Oncology PLGA Polymer in Parenteral Formulation
Webinar on Revolutionizing Oncology: PLGA Polymer in Parenteral Formulation
Leuprolide Depot – Long-acting injectable formulation technologies
Double Emulsion –solvent extractionAn aqueous solution of the peptide (which may contain excipients such as gelatin) is first emulsified in a polymer vehicle where the polyesters have been solubilized in an organic solvent (generally dichloromethane or ethyl acetate)....
Bioresorbable solid implants for peptides : Goserelin acetate
Initial burst release
Leuprolide acetate which is a highly active agonist of luteinizing hormone–releasing hormone (LH-RH) potently inhibits their secretion in the pituitary gland and it is useful in the treatment of hormone-dependent diseases in males and females. To eliminate the...
Factors affecting drug release
Prostate Cancer Cure is Possible
The prostate gland is an organ in reproductive anatomy. This small gland sits directly below the bladder and plays a role in producing seminal fluid, which is a component of semen. It also plays a role in hormone production and helps regulate urine flow. Changes in...
PLGA microspheres
Zoladex (Goserelin acetate) and Lupron Depot (Leuprolide acetate) for the treatment of prostate cancer and breast cancer. The use of PLGA and PLA-based delivery systems have made it possible to create extended-release formulations, that can lower the frequency of dosing and lesser side effects from medications